Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation
This is the first case report to highlight severe MTX-induced myelosuppression in an RA patient and to demonstrate the potential of molecular hydrogen therapy in modulating immune markers.
Authors
- Yi‐Jung Ho (ORCID: https://orcid.org/0009-0006-3931-2302)
- SHAN-WEN LUI (ORCID: https://orcid.org/0009-0002-1151-6814)
- Thai Hien Tu (ORCID: https://orcid.org/0000-0002-6674-012X)
- KUANG-YIH WANG
- Jeng‐Wei Lu (ORCID: https://orcid.org/0000-0003-2128-2046)
- Feng‐Cheng Liu (ORCID: https://orcid.org/0000-0003-1291-8946)
- TING-YU HSIEH
Institutions
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- National Defense Medical Center (TW)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14014
- Citations
- 1
- Primary Topic
- Hydrogen's biological and therapeutic effects
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Ministry of Science and Technology, Taiwan
- Tri-Service General Hospital
- National Science and Technology Council